IP Library Granted Patent US 10,471,258
Granted Patent B2
US 10,471,258 · App. 16/046,912 · Granted Nov 12, 2019

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

Inventors: Konstantinos Alataris (Belmont, CA); Andre B. Walker (Monte Sereno, CA); Jon Parker (San Jose, CA); Yougandh Chitre (Santa Clara, CA); Sangsoo Wesley Park (San Jose, CA); James R. Thacker (Homer, AK)
Assignee: Nevro Corp.
A61N1/36071A61N1/0551A61N1/0553A61N1/06A61N1/36021A61N1/36157A61N1/36164A61N1/36167A61N1/36171A61N1/36175A61N1/36182A61N1/3787A61N1/37235A61N1/37241A61N1/37247A61N1/37264A61N1/3605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,471,258
App. No.
16/046,912
Granted
Nov 12, 2019
Kind
B2
Abstract

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (35)

1. A spinal cord modulation system for treating a patient, the system comprising:

a pulse generator that, in operation, generates a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range between 1.5 kHz and 15 kHz;

one or more implantable electrical contacts electrically coupled to the pulse generator and designed to deliver the therapy signal to the patient's spinal cord region; and

an external power source, wherein the external power source is wirelessly coupleable to the pulse generator to transmit power to the pulse generator via RF signals.

2. The system of claim 1 wherein the frequency is in a frequency range between 3 kHz and 10 kHz.

3. The system of claim 1 wherein the frequency is 10 kHz.

4. The system of claim 1 , wherein the therapy signal has an amplitude less than 6 mA.

5. The system of claim 1 , wherein the therapy signal has an amplitude in an amplitude range between 0.5 and 4 mA.

6. The system of claim 1 , wherein the pulse generator, in operation, also generates a paresthesia-generating electrical signal.

7. The system of claim 1 , wherein the pulse generator is implantable.

8. The system of claim 1 , wherein the one or more electrical contacts include a cylindrical contact.

9. The system of claim 1 , wherein the one or more electrical contacts are adapted to deliver the therapy signal to a location proximate to a dorsal root, dorsal root entry zone, or dorsal root ganglion.

10. A spinal cord modulation system for treating pain in a patient, the system comprising:

an implantable signal generator that, in operation, generates a therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range between 1.5 kHz and 10 kHz and an amplitude that does not generate paresthesia in the patient;

two or more implantable electrical contacts electrically coupled to the signal generator and designed to deliver the therapy signal to one or more locations in the patient's spinal cord; and

an external power source, wherein the external power source is wirelessly coupleable to the signal generator to transmit power to the signal generator via electromagnetic induction.

11. The system of claim 10 wherein the frequency is in a frequency range between 3 kHz and 10 kHz.

12. The system of claim 10 wherein the frequency is 10 kHz.

13. The system of claim 10 , wherein the amplitude is under 6 mA.

14. The system of claim 10 , wherein the signal generator, in operation, also generates a paresthesia-generating electrical signal.

15. The system of claim 10 , wherein the external power source is adapted to transmit power to the signal generator using RF signals.

16. The system of claim 10 , wherein the two or more electrical contacts include a cylindrical contact.

17. A spinal cord modulation system for treating a patient, the system comprising:

an implantable pulse generator that, in operation, generates a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range between 1.5 kHz and 10 kHz, and an amplitude in an amplitude range between 0.1 mA and 10 mA;

one or more implantable electrical contacts electrically coupled to the pulse generator and designed to deliver the therapy signal to the patient's spinal cord region; and

an external power source, wherein the external power source is wirelessly coupleable to the pulse generator to transmit power to the pulse generator via electromagnetic induction.

18. The system of claim 17 , wherein the frequency range is between 3 kHz and 10 kHz.

19. The system of claim 17 , wherein the frequency is 10 kHz.

20. The system of claim 17 , wherein the amplitude range is between 0.5 mA and 10 mA.

21. The system of claim 17 , wherein the amplitude range is between 1 mA and 6 mA.

22. The system of claim 17 , wherein the amplitude range is between 0.5 mA and 4 mA.

23. The system of claim 17 , wherein the amplitude range is between 0.1 mA and 3 mA.

24. The system of claim 17 , wherein the pulse generator, in operation, also generates a paresthesia-generating electrical signal.

25. The system of claim 17 , wherein the one or more electrical contacts include a cylindrical contact.

26. The system of claim 17 , wherein the external power source is adapted to transmit power to the pulse generator using RF signals.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2018
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 046976/0927 →
Continuity (7)
Continuation 14821405 · Aug 7, 2015
Continuation 14522500 · Oct 23, 2014
Continuation 14164100 · Jan 24, 2014
Continuation 12765747 · Apr 22, 2010
Provisional Application 61176868 · May 8, 2009
Provisional Application 61171790 · Apr 22, 2009
Related Publication 20180345017A1 · Dec 6, 2018